The views presented in On Balance are those of the authors and do not represent the views of the Society, its Board, or its members.
This post is part of a series on President Trump’s deregulatory record and what we might expect in the new administration.
With the volatility and uncertainty of the first few weeks of the Trump administration, it is hard not to feel overwhelmed. One way to cope with information overload is to focus on issues where one has particular knowledge and interest. For me, that’s the regulatory process and benefit-cost analysis. In that vein, this post reviews some of the most consequential regulatory directives, and concludes that, while there is room for disagreement on details, the general requirement to base regulations on an understanding of benefits and costs remains intact.